$NYXH

Publication relating to transparency notifications

Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) said it received EU transparency notifications. Orin Hirchman-controlled entities acquired voting securities, raising voting rights to 14,534,880 (14.55%) vs a 10% threshold, effective June 10, 2026. Resmed Inc. reported a passive downward crossing below 3%, holding 1,943,828 voting rights (1.95%).

Original reporting
Published Jun 29, 2026, 9:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 29, 2026, 9:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Publication relating to transparency notifications — source image
Decision brief

The 30-second read

$NYXHNeutralLow
01

Why it matters

The article discloses two holder-related events: (1) Orin Hirchman/AIGH-controlled entities crossing above 10% voting rights (14.55% total), and (2) Resmed Inc. passively crossing below the 3% lowest threshold (down to 1.95%).

02

Market read

Ownership/control signals can matter for small/mid-cap risk premia, but this disclosure lacks new operational or financial information.

03

What to watch

Voting-rights percentages are based on a specific denominator date (June 10, 2026); changes in total shares can mechanically move percentages without altering economic exposure.

Relevance 5/10Novelty 5/10Timing: after-hours/dated June 29, 2026 transparency notification referencing a June 10, 2026 threshold cross

Background

Nyxoah SA reports transparency notifications under the EU/Belgian large shareholding disclosure framework, detailing voting-rights threshold crossings.

Company-level read

Ticker impact

$NYXHNeutralMedium confidence
Context

Nyxoah discloses transparency notifications showing Orin Hirchman/AIGH entities crossed the 10% voting-rights threshold on June 10, 2026.

Expected impact

Likely limited/short-lived price impact; watch for follow-through in ownership/control expectations rather than fundamentals.

Evidence & confidence

The filing provides a concrete ownership/voting-rights change (14.55% total) but no new guidance, deal, or enforcement action.

Market effects

No sector-wide read-across; this is company-specific ownership disclosure.

Primarily relevant to Euronext Brussels/Nasdaq NYXH holders; limited broader regional spillover.

Low global relevance; transparency notification without cross-border deal/regulatory action.

Counterpoint

A threshold-crossing transparency notice may reflect passive/administrative changes rather than a new strategic stance, so price reaction can fade quickly.

Key entities

  • Nyxoah SA

    Subject of the transparency notification; voting-rights threshold changes are reported for its shareholders.

  • Orin Hirchman / AIGH Capital Management LLC

    Reported acquisition of voting securities by entities it controls, reaching 14.55% voting rights.

  • Resmed Inc.

    Reported passive downward crossing below the 3% voting-rights threshold to 1.95%.

Related articles

HighAI 9/10

Nyxoah stock surges as sleep apnea study hits endpoints

Nyxoah SA (NYXH) shares rose 11.9% after its ACCCESS U.S. study met primary safety and efficacy endpoints. The Genio system showed a 77.2% Apnea-Hypopnea Index responder rate and zero device-related serious adverse events. The company plans to submit a premarket approval supplement to the FDA for expanded indication.

$NYXHMed

Nyxoah SA (NYXH): Financial results for Q2 2026

Nyxoah SA (NYXH) furnished an SEC Form 6-K — earnings release. ​ Exhibit 99.1 REGULATED INFORMATION Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating Results U.S. commercial execution driving continued launch momentum resulting in 22% sequential U.S. revenue growth in Q2 2026 over Q1 2026 Mont-Saint-Guibert, Belgium –